Valuation GC Genome Corporation

Stocks

End-of-day quote Korea S.E. 23/10/2026			5-day change	1st Jan Change
9,700.00 ^KRW	-3.39%		+5.09%	+42.23%

12-09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
12/06/25	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027
Market Cap ¹	161,298	229,413	-
Change	-	42.23%	-
Enterprise Value (EV) ¹	161.3	170	160.6
Change	-	5.4%	-5.53%
P/E	36.9x	-	-
PBR	-	-	-
PEG	-0x	-	-
Capitalization / Revenue	-	5.88x	4.7x
EV / Revenue	-	4.36x	3.29x
EV / EBITDA	-	-	-
EV / EBIT	-	42.5x	22.9x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	185	-	-
Distribution rate	-	-	-
Net sales ¹	-	39	48.8
EBITDA	-	-	-
EBIT ¹	-	4	7
Net income	4.044	-	-
Net Debt ¹	-	-59.4	-68.8
Reference price ³	6,820.00	9,700.00	9,700.00
Nbr of stocks (in thousands)	23,651	23,651	-
Announcement Date	16/03/26	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GC GENOME CORPORATION	-	4.36x	-	-	173M
CVS HEALTH CORPORATION	13.6x	0.41x	8.58x	2.85%	120B
HCA HEALTHCARE, INC.	15.82x	1.93x	9.64x	0.66%	102B
NATERA, INC.	-281.44x	19.63x	-331.94x	-.--%	58.23B
FRESENIUS SE & CO. KGAA	13.97x	1.53x	9.26x	2.53%	29.08B
QUEST DIAGNOSTICS INCORPORATED	23.47x	2.61x	13.23x	1.37%	26.61B
LABCORP HOLDINGS INC.	23.05x	2.16x	12.37x	0.89%	26.68B
TENET HEALTHCARE CORPORATION	8.15x	1.46x	6.61x	-.--%	21.62B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	28.71x	5.25x	21.8x	2.43%	19.58B
REDE D'OR SÃO LUIZ S.A.	20.23x	1.81x	9.1x	3.51%	18.93B
Average	-14.94x	4.11x	-26.82x	1.58%	42.2B
Weighted average by Cap.	-24.63x	4.10x	-37.06x	1.55%